CD8A and neoplasm: Depletion of CD4+ T cells weakly attenuated the anti-tumor effect of alum-CpG-HH2-NY vaccine, supporting that CD4+T cells might be a potent inducer of humoral immunity and required for CD8+ CTL response[49].